Schroder Investment Management Group’s Spyre Therapeutics SYRE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$1.97M	Buy	129,558 +21,054	+19%	+$320K	﹤0.01%	911
2025 Q1	$1.95M	Sell	108,504 -5,116	-5%	-$91.8K	﹤0.01%	911
2024 Q4	$2.56M	Buy	+113,620	New	+$2.56M	﹤0.01%	887